Li Wang
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Computational Mathematics top 2%
Papers in
- Nephrology 33
-
- Antifungal resistance and susceptibility 14
- SARS-CoV-2 and COVID-19 Research 12
- Co-authors
- David D. Moore (4 shared papers)Todd W. Rice (11 shared papers)Wesley H. Self (10 shared papers)Matthew W. Semler (10 shared papers)Gordon R. Bernard (7 shared papers)David J. Mangelsdorf (1 shared paper)光博 渡辺 (1 shared paper)Johan H. Auwerx (1 shared paper)
- Journals
- Medicine (19 papers)Frontiers in Psychology (11 papers)PLoS ONE (9 papers)Frontiers in Public Health (8 papers)Frontiers in Microbiology (7 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Wang
1.4k papers receiving 28.0k citations
Li Wang's Hit Papers
Peers
Comparison fields: 5 of 219
- Infectious Diseases 2.2k
- Computational Mathematics 63
- Nephrology 1.0k
- Animal Science and Zoology 572
- Library and Information Sciences 129
Countries citing papers authored by Li Wang
This map shows the geographic impact of Li Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wang more than expected).
Fields of papers citing papers by Li Wang
This network shows the impact of papers produced by Li Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wang. The network helps show where Li Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.6k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody responses to SARS-CoV-2 in patients with COVID-19 Hit paper breakdown → | 2020 | 2228 |
| 2 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c Hit paper breakdown → | 2004 | 1190 |
| 3 | Balanced Crystalloids versus Saline in Critically Ill Adults Hit paper breakdown → | 2018 | 963 |
| 4 | Balanced Crystalloids versus Saline in Noncritically Ill Adults Hit paper breakdown → | 2018 | 845 |
| 5 | 2011 | 342 | |
| 6 | 2012 | 262 | |
| 7 | 1996 | 206 | |
| 8 | 2020 | 206 | |
| 9 | 2014 | 204 | |
| 10 | 2017 | 198 | |
| 11 | 2010 | 197 | |
| 12 | 2016 | 188 | |
| 13 | 2005 | 181 | |
| 14 | 2019 | 179 | |
| 15 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 170 |
| 16 | 2018 | 152 | |
| 17 | 2018 | 145 | |
| 18 | 2013 | 136 | |
| 19 | 2012 | 134 | |
| 20 | 2022 | 130 |
About Li Wang
Li Wang is a scholar working on Nephrology, Infectious Diseases, Animal Science and Zoology, Reproductive Medicine and Oncology, having authored 1.6k papers that have together received 29.1k indexed citations. Recurring topics across this work include Animal Nutrition and Physiology (27 papers), Pancreatic and Hepatic Oncology Research (19 papers), Antifungal resistance and susceptibility (14 papers), Obstructive Sleep Apnea Research (12 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Endometriosis Research and Treatment (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Ovarian cancer diagnosis and treatment (10 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Computational Mathematics (63 citations), Nephrology (1.0k citations), Animal Science and Zoology (572 citations) and Library and Information Sciences (129 citations). Li Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include David D. Moore, Todd W. Rice, Wesley H. Self, Matthew W. Semler, Gordon R. Bernard, David J. Mangelsdorf, 光博 渡辺, Johan H. Auwerx, Sander M. Houten and Antonio Moschetta. Their work appears in journals such as Medicine, Frontiers in Psychology, PLoS ONE, Frontiers in Public Health and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.